Wave 15a contract change starts on 1st February for some regions, so to support our customers we sent out our customary contract support packs last week. They contain an essential selection of refreshments, and stationery for NHS pharmacy departments to use during the changeover. We hope our customers enjoy the…

Mawdsleys and Oncoscience GMbH have launched a Named Patient Supply Program to allow Oncologists in the United Kingdom (UK) and Ireland to obtain access to CIMAher® (Nimotuzumab) on an unlicensed basis for the treatment of various types of cancer.   Nimotuzumab has been approved for marketing in 25 different countries worldwide for a variety of…